Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Coenzyme Q10 in Sepsis
NCT05293132Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Feb 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of montelukast, coenzyme q10 in sepsis, sponsored by Ain Shams University. Started Feb 2022; status: completed.
02
Drugs
montelukastcoenzyme q10
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT05293132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05293132.